Table 1 PacELF leadership at WHO Division of Pacific Technical Support, Suva, Fiji, showing major strategies and achievements, 1999 to 2017

1999 to 2005: Dr. Kazuyo Ichimori

 • Baseline surveys conducted using ICT

 • Established a coordinating body and PacELF office and warehouse

 • Established logistics systems for drugs, diagnostics and data reporting

 • Regular program managers’ meetings

 • Development of M&E plan using A (baseline), B (sentinel), C (stop MDA), and D (transmission) surveys; C survey was in all ages and D survey in children

 • First countries stopped MDA in 2004

 • Initiated morbidity surveys

 • Published PacELF book

2006 to 2008: Dr. Corinne Capuano

 • M&E guideline revision—maintained stop MDA (C) surveys in all ages and transmission surveys in children, with mop up around positive cases

 • Introduced test and treat strategies in three countries

 • Improvements to behavior change communication

 • Morbidity surveys and hydrocoele surgery programs in Fiji

 • Maintained MDA and post-MDA surveillance

2009 to 2011: Dr. Sunghye Kim

 • Preparation of elimination dossiers

 • Maintained MDA and post-MDA surveillance

2012 to 2017: Dr. Padmasiri Aratchige

 • Maintained MDA as needed and oversaw transmission assessment surveys

 • Validation of elimination dossiers approved for Vanuatu, Republic of Marshall Islands, Niue, Cook Is, and Tonga